Blog Posts

DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE EXTENDING MONOPOLIES, KEEPING PRICES HIGH ON GLP-1S

Apr 22, 2025

Novo Nordisk Alone Has Filed 320 Patents on Single Active Ingredient Behind Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Apr 16, 2025

Big Pharma Giant Johnson & Johnson Reports Earnings That Beating Wall Read More

THEY SAID IT! SENATE JUDICIARY CALLS OUT BIG PHARMA’S ANTI-COMPETITIVE PRACTICES THAT KEEP PRESCRIPTION DRUG PRICES HIGH

Apr 7, 2025

Senators on Both Sides of the Aisle Highlight Concerns with Big Pharma’s Read More

BIG PHARMA WATCH: PFIZER AVOIDED PAYING BILLIONS IN U.S. TAXES THROUGH “EGREGIOUS TAX GIMMICK”

Apr 2, 2025

Big Pharma Giant Used “Round-Tripping” Tax Avoidance Scheme to Attribute Read More

They Said It!: Lawmakers And FDA Nominee Highlight Greater Competition As Critical To Lowering Prescription Drug Prices

Mar 12, 2025

U.S. Senate Confirmation Hearing Called Attention to Big Pharma’s Egregious Read More

SECOND OPINION: PhRMA REDUXES SAME DEBUNKED ARGUMENTS ON INNOVATION

Feb 26, 2025

Big Pharma’s Innovation Rhetoric Designed to Keep Drug Prices High Rather Read More

THEY SAID IT! PRESIDENT TRUMP CALLS OUT BIG PHARMA’S EGREGIOUS PRICING FOR DIABETES AND WEIGHT LOSS DRUGS IN U.S. MARKET

Feb 19, 2025

Brand Name Manufacturers’ Prices for Blockbuster GLP-1 Medications Are Read More

BIG PHARMA EARNINGS WATCH: GILEAD

Feb 13, 2025

Brand Name Drug Company Known for Egregious Product-Hopping Strategy Beats Read More

BIG PHARMA EARNINGS WATCH: ASTRAZENECA, BRISTOL MYERS SQUIBB AND ELI LILLY

Feb 12, 2025

Eli Lilly Signals Plan to Maintain Unsustainably High Prices on Blockbuster Read More

BIG PHARMA EARNINGS WATCH: MERCK AND PFIZER

Feb 7, 2025

Pharmaceutical Giants Continue to Outperform Wall Street Projections While Read More

BIG PHARMA EARNINGS WATCH: AMGEN, GSK AND NOVO NORDISK

Feb 7, 2025

Major Pharmaceutical Companies Continue Growing Revenues While Sticking With Read More

BIG PHARMA EARNINGS WATCH: ABBVIE, NOVARTIS AND ROCHE

Feb 6, 2025

Big Pharma Giants Report Higher-Than-Expected Q4 Earnings Amid Continued Price Read More